VanEck Pharmaceutical ETFPPH
Price as of · delayed, not real-time
An exchange-traded fund that tracks the NYSE Arca Pharmaceutical Index, providing exposure to large-cap U.S. and international pharmaceutical companies. Investors use it to gain diversified access to drug developers and manufacturers, with top holdings typically including major names like Eli Lilly, Pfizer, and Merck. The fund is a benchmark for the pharmaceutical industry's performance, often monitored for sector rotation and healthcare allocation decisions.
Congressional Interest in VanEck Pharmaceutical ETF (PPH)
2 members of Congress have disclosed 5 trades in VanEck Pharmaceutical ETF (PPH), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 4 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Who in Congress Is Trading PPH?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-04-23 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2018-04-20 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2018-04-20 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2018-04-12 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2011-10-11 | JAMES B. RENACCI | buy | $3,111.57 |